The complete metabolic/molecular response to chemotherapy combined with [177Lu]Lu-FAP-2286 in metastatic breast cancer

Ethics approval and consent to participate

This prospective study was approved by the Research Ethics Committee of Shahid Beheshti University of Medical Sciences in Tehran, Iran (IR.SBMU.CRC.REC.1402.040) and a written informed consent was obtained from the patient.

Consent for publication

All patients participating in the present study and the authors consent to publish and print the information contained in this article.

Competing interests

The authors declare that they have no competing interests.

留言 (0)

沒有登入
gif